Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma (Annals of Oncology (2003) vol. 14 (i17-i20))

Julie Marie Vose, V. Sneller

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalAnnals of Oncology
Volume15
Issue number3
DOIs
StatePublished - Mar 1 2004

Fingerprint

Ifosfamide
Carboplatin
Etoposide
Non-Hodgkin's Lymphoma
Outpatients
Rituximab

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

@article{12f8b15b10854030b7ff9e4c2565c86f,
title = "Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma (Annals of Oncology (2003) vol. 14 (i17-i20))",
author = "Vose, {Julie Marie} and V. Sneller",
year = "2004",
month = "3",
day = "1",
doi = "10.1093/annonc/mdh129",
language = "English (US)",
volume = "15",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma (Annals of Oncology (2003) vol. 14 (i17-i20))

AU - Vose, Julie Marie

AU - Sneller, V.

PY - 2004/3/1

Y1 - 2004/3/1

UR - http://www.scopus.com/inward/record.url?scp=1842555262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842555262&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh129

DO - 10.1093/annonc/mdh129

M3 - Comment/debate

VL - 15

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -